Cargando…
Emerging therapeutics in the management of COVID-19
The severe acute respiratory syndrome coronavirus 2 (coronavirus disease 2019, COVID-19) pandemic has placed a tremendous burden on healthcare systems globally. Therapeutics for treatment of the virus are extremely inconsistent due to the lack of time evaluating drug efficacy in clinical trials. Cur...
Autores principales: | Kichloo, Asim, Albosta, Michael, Kumar, Akshay, Aljadah, Michael, Mohamed, Mohamed, El-Amir, Zain, Wani, Farah, Jamal, Shakeel, Singh, Jagmeet, Kichloo, Akif |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7852573/ https://www.ncbi.nlm.nih.gov/pubmed/33585175 http://dx.doi.org/10.5501/wjv.v10.i1.1 |
Ejemplares similares
-
Utilization of extracorporeal membrane oxygenation during the COVID-19 pandemic
por: Kichloo, Asim, et al.
Publicado: (2021) -
COVID-19 and Acute Lupus Pneumonitis: Diagnostic and Treatment Dilemma
por: Kichloo, Asim, et al.
Publicado: (2020) -
COVID-19 and Hypercoagulability: A Review
por: Kichloo, Asim, et al.
Publicado: (2020) -
Atezolizumab-Induced Bell’s Palsy in a Patient With Small Cell Lung
Cancer
por: Kichloo, Asim, et al.
Publicado: (2020) -
Pembrolizumab-Induced Diabetes Mellitus Presenting as Diabetic Ketoacidosis in a Patient With Metastatic Colonic Adenocarcinoma
por: Kichloo, Asim, et al.
Publicado: (2020)